Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 3,853 | 5,577 | 5,640 | 1,675 | 930 |
| Cost of Goods | 4,094 | 2,380 | 1,692 | 909 | 767 |
| Gross Profit | -241 | 3,197 | 3,948 | 766 | 163 |
| Operating Expenses | 13,887 | 22,381 | 31,148 | 28,616 | 31,883 |
| Operating Income | -14,034 | -18,804 | -26,508 | -26,941 | -30,953 |
| Interest Expense | 1,933 | 3,358 | 965 | 3,329 | 1,414 |
| Other Income | 2,469 | 7,354 | 1,486 | 516 | 1,935 |
| Pre-tax Income | -13,498 | -14,808 | -25,987 | -29,754 | -30,432 |
| Income Tax | 1 | 9 | -33 | 90 | 13 |
| Net Income Continuous | -13,499 | -14,817 | -25,954 | -29,844 | -30,445 |
| Net Income Discontinuous | 5,672 | -3,237 | N/A | N/A | N/A |
| Minority Interests | 658 | -1,569 | -2,075 | -3,206 | -2,652 |
| Net Income | $-8,485 | $-16,485 | $-23,879 | $-26,638 | $-27,793 |
| EPS Basic Total Ops | -1.08 | -2.90 | -5.20 | -6.50 | -6.90 |
| EPS Basic Continuous Ops | -1.71 | -2.60 | -5.66 | -7.24 | -7.53 |
| EPS Basic Discontinuous Ops | 0.72 | -0.57 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.08 | -2.90 | -5.20 | -6.50 | -6.90 |
| EPS Diluted Continuous Ops | -1.71 | -2.60 | -5.66 | -7.24 | -7.53 |
| EPS Diluted Discontinuous Ops | 0.72 | -0.57 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.70 | -2.89 | -5.20 | -6.50 | -6.90 |
| EBITDA(a) | $-11,567 | $-16,952 | $-23,896 | $-24,361 | $-28,719 |